|
|
Volumn 26, Issue 6, 2002, Pages 230-232
|
|
Medico-legal implications of drug treatment in dementia: Prescribing out of licence
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBAMAZEPINE;
CARBONIC ACID;
CHLORPROMAZINE;
CITALOPRAM;
DIAZEPAM;
DROPERIDOL;
FLUOXETINE;
FLUPENTIXOL;
HALOPERIDOL;
LITHIUM;
LORAZEPAM;
NON PRESCRIPTION DRUG;
OLANZAPINE;
PAROXETINE;
PROMAZINE;
PSYCHOTROPIC AGENT;
QUETIAPINE;
RISPERIDONE;
SERTRALINE;
SULPIRIDE;
THIORIDAZINE;
TRAZODONE;
TRIFLUOPERAZINE;
VALPROIC ACID;
ZUCLOPENTHIXOL DECANOATE;
ARTICLE;
BEHAVIOR DISORDER;
DEMENTIA;
DRUG INFORMATION;
DRUG LEGISLATION;
EVIDENCE BASED MEDICINE;
GOOD CLINICAL PRACTICE;
GOOD MANUFACTURING PRACTICE;
HUMAN;
INFORMED CONSENT;
LICENSING;
MEDICOLEGAL ASPECT;
NATIONAL HEALTH SERVICE;
PRESCRIPTION;
PSYCHOSIS;
|
|
EID: 0036275917
PISSN: 09556036
EISSN: None
Source Type: Journal
DOI: 10.1192/pb.26.6.230 Document Type: Article |
|
Times cited : (4)
|
|
References (15)
|
